Abnormal inhibin A and inhibin B secretion in obese women with and without insulin resistance

Abstract

Aim. The present study aimed to establish inhibin A and B serum levels during the menstrual cycle of obese women, and its usefulness as an index of luteal-phase follicular development.

Materials and methods. Twenty-one obese patients (mean body mass index: 34.9 ± 3.7 kg/m²; range: 30.0–45.0 kg/m²) were submitted to basal hormonal measurements and an oral glucose tolerance test after challenge with 75 g glucose. Progesterone and inhibin A and B levels were determined 5–7 days after the menstrual cycle and 7 days prior to expected menses.

Results. As expected, an increase in inhibin A and a decrease in inhibin B were observed when first-phase samples were compared with samples obtained after 15–20 days. On the other hand, the percentage variation of both inhibin A and B was at least four times smaller than the values for normal women described previously by other authors employing the same enzyme-linked immunosorbent assays. A small number of obese women presented ovulatory cycles characterized by progesterone concentration higher than 5.8 ng/ml. The percentage elevation ( > 190%) of inhibin A in the second samples was in agreement with the progesterone levels, but it seemed to be more sensitive for the detection of follicle luteinization.

Conclusion. We conclude that obese women present less percentage variation of both inhibin A and B during the menstrual cycle, associated with a low frequency of ovulatory cycles. In obese women, the percentage increase of inhibin A can represent an additional marker to recognize follicle luteinization.

• Obesity
• inhibin
• anovulation
• follicular luteinization
• insulin resistance